liraglutide
Pre-clinicalCompleted 1 views this week 0 watching💤 Quiet
Interest: 26/100
26
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Diabetes
Conditions
Diabetes, Diabetes Mellitus, Type 2
Trial Timeline
Feb 1, 2011 → Mar 1, 2013
NCT ID
NCT01288326About liraglutide
liraglutide is a pre-clinical stage product being developed by Novo Nordisk for Diabetes. The current trial status is completed. This product is registered under clinical trial identifier NCT01288326. Target conditions include Diabetes, Diabetes Mellitus, Type 2.
What happened to similar drugs?
20 of 20 similar drugs in Diabetes were approved
Approved (20) Terminated (0) Active (0)
Hype Score Breakdown
Clinical
3
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (20)
| NCT ID | Phase | Status |
|---|---|---|
| NCT06283641 | Pre-clinical | Completed |
| NCT05438186 | Pre-clinical | Withdrawn |
| NCT03888157 | Pre-clinical | Completed |
| NCT03560336 | Pre-clinical | Completed |
| NCT03479762 | Pre-clinical | Completed |
| NCT02967757 | Pre-clinical | Completed |
| NCT02505334 | Phase 3 | Completed |
| NCT02472717 | Phase 2 | Withdrawn |
| NCT02255266 | Pre-clinical | Completed |
| NCT02321878 | Pre-clinical | Completed |
| NCT02207348 | Phase 1 | Completed |
| NCT01821846 | Pre-clinical | Completed |
| NCT01890993 | Pre-clinical | Completed |
| NCT01499108 | Approved | Completed |
| NCT01542242 | Approved | Terminated |
| NCT01345734 | Pre-clinical | Completed |
| NCT01394341 | Approved | Completed |
| NCT01403025 | Pre-clinical | Completed |
| NCT01288326 | Pre-clinical | Completed |
| NCT01212133 | Pre-clinical | Completed |
Competing Products
20 competing products in Diabetes